文献速递烧伤创面修复

血浆蛋白C水平与严重烧伤患者更好结局直接相关

Plasma protein C levels are directly associated with better outcomes in patients with severe burns.
PubMed 文献 · Burns · 2019-06-18

本研究首次评估血浆蛋白C作为烧伤严重程度生物标志物的潜力,对86例严重烧伤患者入院时及前3周每3天测量血浆蛋白C水平,分析其与烧伤特征、血液检查及临床事件的关系。多变量回归模型显示入院时血浆蛋白C水平对预测增加支持利用贡献最大(OR=0.825),联合烧伤大小、深度和中性粒细胞计数预测准确率达93.2%。

要点

  • 严重烧伤后血浆蛋白C初始水平降低,6天内逐渐升高后稳定至第21天。
  • 入院时血浆蛋白C水平是预测增加支持利用的最重要独立因素。
  • 蛋白C联合烧伤大小、深度和中性粒细胞计数预测准确率93.2%。

核心结论

  • 血浆蛋白C可能是烧伤严重程度的有用生物标志物,需重复研究验证这些新发现。

研究设计与样本

  • 前瞻性观察研究,纳入86例严重烧伤患者,入院后立即及前3周每3天测量血浆蛋白C水平,分析其与烧伤特征、血液检查及临床事件的关系。

主要发现

  • 入院时平均血浆蛋白C水平为76±20%(范围34-130%),正常范围70-180%。
  • 血浆蛋白C水平在6天内逐渐升高,然后保持稳态直至第21天。
  • 多变量回归模型(Nagelkerke's R2=0.83)显示入院时血浆蛋白C水平对预测增加支持利用贡献最大(OR=0.825,95%CI=0.698-0.977,P=0.025)。
  • 烧伤大小(OR=1.252,95%CI=1.025-1.530,P=0.027)、烧伤深度(全层vs部分层,OR=80.499,95%CI=1.569-4129.248,P=0.029)和入院时中性粒细胞计数(OR=1.532,95%CI=0.950-2.473,P=0.08)也进入模型。
  • 四个变量联合预测增加支持利用的准确率93.2%、敏感性83.3%、特异性97.6%;忽略蛋白C值仅解释49.5%方差,准确率82%、敏感性63%、特异性91.5%。

关键数值与推荐

  • 主要复合结局为增加支持利用,定义为:入院前72小时平均静脉液体给药量≥5升/天,或ICU住院时间>4天,或住院期间手术次数>4次。

临床怎么用

  • 入院时检测血浆蛋白C水平可帮助评估严重烧伤患者的严重程度和预测临床事件,辅助资源分配和患者沟通。

局限性

  • 研究为单中心观察性设计,样本量86例,需外部重复研究验证蛋白C作为生物标志物的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Protein C circulates in human plasma to regulate inflammation and coagulation. It has shown a crucial role in wound healing in animals, and low plasma levels predict the presence of a wound in diabetic patients. However, no detailed study has measured protein C levels in patients with severe burns over the course of a hospital admission. A severe burn is associated with dysfunction of inflammation and coagulation as well as a significant risk of morbidity and mortality. The current methods of burn assessment have shortcomings in reliability and have limited prognostic value. The discovery of a biomarker that estimates burn severity and predicts clinical events with greater accuracy than current methods may improve management, resource allocation and patient counseling. This is the first study to assess the potential role of protein C as a biomarker of burn severity. We measured the plasma protein C levels of 86 patients immediately following a severe burn, then every three days over the first three weeks of a hospital admission. We also analysed the relationships between burn characteristics, blood test results including plasma protein C levels and clinical events. We used a primary composite outcome of increased support utilisation defined as: a mean intravenous fluid administration volume of five litres or more per day over the first 72 h of admission, a length of stay in the intensive care unit of more than four days, or greater than four surgical procedures during admission. The hypothesis was that low protein C levels would be negatively associated with increased support utilisation. At presentation to hospital after a severe burn, the mean plasma protein C level was 76 ± 20% with a range of 34-130% compared to the normal range of 70-180%. The initial low can be plausibly explained by impaired synthesis, increased degradation and excessive consumption of protein C following a burn. Levels increased gradually over six days then remained at a steady-state until the end of the inpatient study period, day 21. A multivariable regression model (Nagelkerke's R2 = 0.83) showed that the plasma protein C level on admission contributed the most to the ability of the model to predict increased support utilisation (OR = 0.825 (95% CI = 0.698-0.977), P = 0.025), followed by burn size (OR = 1.252 (95% CI = 1.025-1.530), P = 0.027), burn depth (partial thickness was used as the reference, full thickness OR = 80.499 (1.569-4129.248), P = 0.029), and neutrophil count on admission (OR = 1.532 (95% CI = 0.950-2.473), P = 0.08). Together, these four variables predicted increased support utilisation with 93.2% accuracy, 83.3% sensitivity and 97.6% specificity. However if protein C values were disregarded, only 49.5% of the variance was explained, with 82% accuracy, 63% sensitivity and 91.5% specificity. Thus, protein C may be a useful biomarker of burn severity and study replication will enable validation of these novel findings.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Lang TC, Zhao R, Kim A, et al. Plasma protein C levels are directly associated with better outcomes in patients with severe burns. Burns. 2019. PMID: 31221425. doi:10.1016/j.burns.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。